Verastem, Inc. (VSTM)
VSTM Stock Chart More Charts
VSTM Price/Volume Stats
| Current price | $5.02 |
| Prev. close | $4.75 |
| Day low | $4.70 |
| Day high | $5.05 |
| 50-day MA | $3.83 |
| 200-day MA | $3.74 |
| 52-week high | $5.71 |
| 52-week low | $1.92 |
| Volume | 2,389,700 |
| Avg. volume | 932,890 |
| Dividend yield | N/A |
| Market Cap | 287.70M |
VSTM Returns
| 1-mo | 19.52% |
| 3-mo | 51.66% |
| 6-mo | 37.16% |
| 1-year | 113.62% |
| 3-year | -40.38% |
| 5-year | -45.20% |
| YTD | 63.52% |
| 2017 | 174.11% |
| 2016 | -39.78% |
| 2015 | -79.65% |
| 2014 | -19.82% |
| 2013 | 29.69% |
Verastem, Inc. (VSTM) Company Bio
Verastem, Inc. focuses on discovering and developing drugs for the treatment of cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. The company was founded in 2010 and is based in Needham, Massachusetts.
Loading social stream, please wait...